Skip to content
Subscriber Only

U.S. Will Test Multiple Ebola Drugs in Clinical Trials

Updated on

U.S. health officials are planning a clinical trial that would involve multiple experimental Ebola drugs in an effort to speed approval of the medicines.

The National Institute of Allergy and Infectious Diseases and the Food and Drug Administration are working to complete a protocol and prioritize which treatments will be studied, said Edward Cox, director of the FDA’s Office of Antimicrobial Products. The trial will require some patients to forgo experimental drugs so researchers can see if the treatments are better than the standard of care, Cox said.